| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 06/28/2006 | CN1794989A N-(((((1,3-thiazol-2-yl)amino)carbonyl)phenyl)sulfonyl)phenylalanine derivatives and related compounds for the treatment of diabetes |
| 06/28/2006 | CN1794987A Nitrooxyderivatives of fluvastatin, pravastatin, cerivastatin, atorvastatin and rosuvastatin as cholesterol-reducing agents with improved anti-inflammatory, antithrombotic and antiplatelet activity |
| 06/28/2006 | CN1794978A Pharmaceutical compositions comprising atorvastatin manufactured without granulation |
| 06/28/2006 | CN1793165A Process for producing asparagus saponin |
| 06/28/2006 | CN1793156A Luteolin-7-O-bata-glucuronide and its extracting process and application thereof |
| 06/28/2006 | CN1793134A Process for separating purifying actived tea polyphenols |
| 06/28/2006 | CN1793132A Derivative of cyclo membranousol kind and application thereof |
| 06/28/2006 | CN1792374A Traditional Chinese medicine prepns. for treating diabete |
| 06/28/2006 | CN1792372A Traditional Chinese medicine prepn. for treating diabetes |
| 06/28/2006 | CN1792254A Health-care food contg. giant salamander, and its production method |
| 06/28/2006 | CN1792250A Nutrient food for reducing-weight, preventing and treating fatty liver disease, and its prodn. method |
| 06/28/2006 | CN1792209A Fructus ligustri lucidi health-care tea, and its prepn. method |
| 06/28/2006 | CN1261453C Platelet-derived growth factor D, DNA coding and uses thereof |
| 06/28/2006 | CN1261430C Novel benzazepines and related heterocyclic derivatives which are useful as orexin receptor antagonists |
| 06/28/2006 | CN1261429C Cholesterol lowering benzo [b] thiophenes and benzo[d] isothiazoles |
| 06/28/2006 | CN1261419C Substituted 3-phenyl-5-alkoxi-1,3,4-oxdiazol-2-one and use thereof for inhibiting hormone-sensitive lipase |
| 06/28/2006 | CN1261414C Pyridineamido derivatives as inhibitors of monoamine oxidase (MAO-B) |
| 06/28/2006 | CN1261158C Application of growth hormone for preparation medicine with induced nerve protection function |
| 06/28/2006 | CN1261150C Chinese medicine for health preserving and fat reducing by umbilical treatment |
| 06/28/2006 | CN1261115C Chinese traditional medicine preparation for treating diabetic chronic retinopathy and preparation method thereof |
| 06/28/2006 | CN1261098C p38-alpha kinase inhibitors |
| 06/28/2006 | CN1261096C Compound preparation of reveratrol and application |
| 06/28/2006 | CN1261094C New use of lipase inhibitors |
| 06/28/2006 | CN1261033C White red-rooted salvia root tea and its preparing method |
| 06/27/2006 | US7067667 Aminoalkyl-3, 4-dihydroquinoline derivatives as no-synthase inhibitors |
| 06/27/2006 | US7067554 Method for the synthesis of compounds of formula I and their uses thereof |
| 06/27/2006 | US7067553 Thiourea compounds and the pharmaceutical compositions containing the same |
| 06/27/2006 | US7067543 Anthranilic acid amides and pharmaceutical use thereof |
| 06/27/2006 | US7067540 Antiinflammatory agents; antiarthritic agents; antihistamines; sepsis shock; antidiabetic agents; bone disorders |
| 06/27/2006 | US7067539 Cannabinoid receptor ligands |
| 06/27/2006 | US7067529 a 1-benzoyl-6- or 7-methoxy-isoquinoline; antidiabetic agents; Type II diabetes |
| 06/27/2006 | US7067528 1, 2-dihydro-2-oxo-1, 8-naphthyridine derivative |
| 06/27/2006 | US7067525 Compounds useful as modulators of Melanocortin Receptors and pharmaceutical compositions comprising same |
| 06/27/2006 | US7067524 estrogen receptor agaonists or antagonists; therapy or prophylaxis for endometriosis; 8-fluoro-6-(3-fluoro-4-hydroxyphenyl)-2-naphthol |
| 06/27/2006 | US7067521 1-[alkyl], 1-[(heteroaryl)alkyl] and 1-[(aryl)alkyl]-7pyridinyl-imidazo[1,2-alpha]pyrimidin-5(1H)-one derivatives |
| 06/27/2006 | US7067520 Antidiabetic agents; hypoglycemic agents; antilipemic agents; dietetics |
| 06/27/2006 | US7067519 human orexin receptor antagonists; analgesics, antidiabetic agents; sleep apnea, insomnia |
| 06/27/2006 | US7067517 Use of compounds for decreasing activity of hormone-sensitive lipase |
| 06/27/2006 | US7067515 Quinuclidines-substituted-multi-cyclic-heteroaryls for the treatment of disease |
| 06/27/2006 | US7067514 Pyrimidine compounds |
| 06/27/2006 | US7067512 Substituted 1,4-benzodiazepines and uses thereof |
| 06/27/2006 | US7067503 17-aryl linker derivatised estrogen 3-sulphamates as inhibitors of steroid sulphatase |
| 06/27/2006 | US7067498 Feeding low viscosity fiber and starch hydrolyzates; antidiabetic agents |
| 06/27/2006 | US7067480 Compositions and methods of use for anti-inflammatory agents |
| 06/27/2006 | US7067285 Desaturase genes and uses thereof |
| 06/27/2006 | US7067154 Pharmaceutical compositions containing Vitamin D and calcium, their preparation and therapeutic use |
| 06/27/2006 | US7067133 Expression vector encoding a fusion protein with segments of a region which binds to an epitope or fragment and fragment or whole proteins that can cross the blood brain barrier |
| 06/27/2006 | CA2408909C Azabicyclo[3.2.1]octane triazolyl tropane derivatives as ccrs5 modulators |
| 06/22/2006 | WO2006066174A1 Thiazolopyridinone derivates as mch receptor antagonists |
| 06/22/2006 | WO2006066173A2 Novel mch receptor antagonists |
| 06/22/2006 | WO2006065706A1 N-biaryl and n-arylheteroaryl 2-substituted piperazine derivatives as modulators of the 5ht2c receptor useful for the treatment of disorders related thereto |
| 06/22/2006 | WO2006065600A2 N-biaryl and n-arylheteroaryl piperazine derivatives as modulators of the 5ht2c receptor useful for the treatment of disorders related thereto |
| 06/22/2006 | WO2006065214A1 Tri (hydroxymethyl) methylamine salt or an ethanol amine salt of (2s) -2-ethoxy-3- (4-{2- [hexyl (2- phenylethyl) amino] - 2 -oxoethoxy} phenyl) propanoic acid |
| 06/22/2006 | WO2006064826A1 MEDICINAL COMPOSITION CONTAINING FBPase INHIBITOR |
| 06/22/2006 | WO2006064761A1 Adiponectin regultor and foods, drinks, food aditives and drugs containing the same |
| 06/22/2006 | WO2006064757A1 Aminocarboxylic acid derivative and medicinal use thereof |
| 06/22/2006 | WO2006064744A1 Medicinal composition for treating diabetes |
| 06/22/2006 | WO2006064232A1 Amine salts of (-)-2-((2-(4-hydroxyphenyl)ethyl)thio)-3-(4-(2-(4-((methylsulfonyl)oxy) phenoxy)ethyl)phenyl) propanoic acid |
| 06/22/2006 | WO2006064189A1 Oxadiazole derivatives as dgat inhibitors |
| 06/22/2006 | WO2006064150A1 Method for obtaining stabilised natural polyphenols, polyphenols thus obtained, and use of said polyphenols in the metabolism of glucids |
| 06/22/2006 | WO2006064115A1 USE OF NUCLEOTIDE SEQUENCES PREFERABLY INTERACTING WITH THE TRANSCRIPTION COMPLEX PPAR α |
| 06/22/2006 | WO2006064061A1 Amines, combination of amines and vanadium and amine vanadium salts for the treatment or prevention of dyslipidemia |
| 06/22/2006 | WO2006063828A1 4-cycloalkyl-substituted tetrahydrochinoline derivatives and use thereof as medicaments |
| 06/22/2006 | WO2006063718A1 Piperazinyl pyridine derivatives as anti-obesity agents |
| 06/22/2006 | WO2006063714A1 Pharmaceutical compositions for the treatment of cellulite |
| 06/22/2006 | WO2006063697A1 Hydroxybiphenyl carboxylic acids and derivatives, method for producing the same and their use |
| 06/22/2006 | WO2006063681A1 Use of substituted cyclopropane acid derivatives for producing drugs for use in the treatment of metabolic syndrome |
| 06/22/2006 | WO2006040047A3 Diagnostics and therapeutics for diseases associated with rho/rac-interacting citron kinase (cit) |
| 06/22/2006 | WO2006012415A3 Rage protein derivatives |
| 06/22/2006 | WO2006008008A3 Diagnostics and therapeutics for diseases associated with hepatocyte nuclear factor 4, alpha (hnf4a) |
| 06/22/2006 | WO2006000567A3 Use of glp-1 receptor agonists and / or dpp-iv inhibitors in combination with proton pump inhibitors and ppar agonists for the preparation of a medicament for the treatment of diabetes type i i and impaired pancreatic beta-cell function |
| 06/22/2006 | US20060135794 Process for recovery of plant sterols from by-product of vegetable oil refining |
| 06/22/2006 | US20060135785 Alpha-phenyl acetanilide derivatives having an acat inhibiting activity and the therapeutic application thereof |
| 06/22/2006 | US20060135776 4-Cyanopyrazole-3-carboxamide derivatives, preparation, and application thereof |
| 06/22/2006 | US20060135624 Natural compound useful for treating diabetes, its preparation and use |
| 06/22/2006 | US20060135614 Novel compounds |
| 06/22/2006 | US20060135611 Use of 2,5-dihydroxybenzenesulfonic compounds for the treatment of disorders based on an impairment of no production and/or of regulation of edhf function |
| 06/22/2006 | US20060135606 Use of carnitines for the prevention and/or treatment of disorders caused by the andropause |
| 06/22/2006 | US20060135590 Selected fused pyrrolocarbazoles |
| 06/22/2006 | US20060135587 Method and compounds for promoting healing and reducing inflammation |
| 06/22/2006 | US20060135578 Five-membered heterocyclic compounds |
| 06/22/2006 | US20060135577 EDG (Endothelial differentiation gene)-2 antagonist; chronic asthma, glomerular nephritis, obesity, prostate hyperplasia, arteriosclerosis, atopic dermatitis; (1) 3-(N-((2-(2-((4-chlorobenzylamino)carbonyl)phenyl)phenyl)carbonyl)-N-(2-(2-methoxyphenyl)ethyl)amino)propanoic acid |
| 06/22/2006 | US20060135573 Benzothiazole-4,7-diones and benzoxazole-4,7-diones with substituents in position 5 or 6 and method for production thereof |
| 06/22/2006 | US20060135572 Compounds as for example, 2'-[1-[(2R)-3-[[1-(3-fluoro-4-methylphenyl)-2-methylpropan-2-yl]amino]-2-hydroxypropoxy]ethyl]-3-methylbiphenyl-4-carboxylic acid, having a calcium-sensing receptor antagonistic action; therapeutic drug for osteoporosis |
| 06/22/2006 | US20060135567 Comprehensive pharmacologic therapy for treatment of obesity |
| 06/22/2006 | US20060135566 E.g., N-[5-(2-Benzoylamino-4-pyridyl)-4-(3,5-dimethylphenyl)-1,3-thiazol-2-yl]acetamide,; the compounds have adenosine A3 receptor antagonistic activity, a p38 MAP kinase inhibitory action, and a TNF- alpha production-inhibitory action |
| 06/22/2006 | US20060135560 Prevention and treatment of cardiovascular pathologies with tamoxifen analogues |
| 06/22/2006 | US20060135555 Ring fused pyrazole derivatives as CRF antagonists |
| 06/22/2006 | US20060135534 Pyrazine based inhibitors of glycogen synthase kinase 3 |
| 06/22/2006 | US20060135531 Modulators of dopamine neurotransmission |
| 06/22/2006 | US20060135523 2-substituted 5,6-diaryl-pyrazine derivatives as cb1 modulator |
| 06/22/2006 | US20060135521 Administering racemic reboxetine or a salt thereof for inhibition of norepinephrine reuptake |
| 06/22/2006 | US20060135520 Method of treating peripheral neuropathy |
| 06/22/2006 | US20060135519 5-aryltetrazole compounds and compositions thereof |
| 06/22/2006 | US20060135471 Anti-obesity compositions |
| 06/22/2006 | US20060135444 Combination of flavonoid and procyanidin for the reduction of the mammalian appetite |
| 06/22/2006 | US20060135428 kringle peptides; peptidase stabilized |
| 06/22/2006 | US20060135419 Proteins involved in the regulation of energy homeostasis |
| 06/22/2006 | US20060135415 Immunomodulation and effect on cell processes relating to serotonin family receptors and the blood-brain barrier |
| 06/22/2006 | US20060134715 Optically detectable organophosphonates |